The Epstein-Barr Virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway

Virology

Volumn 280, Issue 2, 2001, Pages 183-198

  Vockerodt, Martina ^a   Haier, Birgit ^a   Buttgereit, Peter ^a,c   Tesch, Hans ^a   Kube, Dieter ^a,b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Burkitt's lymphoma; EBV LMP1; Hodgkin's disease; Interleukin 10; NF B; p38 SAPK2

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CD40 ANTIGEN; IMIDAZOLE DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 10; LATENT MEMBRANE PROTEIN 1; PYRIDINE DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BURKITT LYMPHOMA; CARBOXY TERMINAL SEQUENCE; CELL GROWTH; CELL TRANSFORMATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPSTEIN BARR VIRUS; GENE ACTIVATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; REED STERNBERG CELL; SIGNAL TRANSDUCTION; VIRUS INFECTION;

HUMAN HERPESVIRUS 4; STAPHYLOCOCCUS PHAGE 187;

EID: 0035866322     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0768     Document Type: Article

References (62)

1. Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10
2. Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines
3. Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10
4. Serum interleukin-10 in non-Hodgkin's lymphoma: A prognostic factor
5. Selective regulation of cytokine induction by adenoviral gene transfer of IkappaBalpha into human macrophages: Lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-kappaB independent
6. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10
7. NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells
8. Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: Lack of correlation with prognosis
9. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
10. Epstein-Barr virus and Hodgkin's disease: Transcriptional analysis of virus latency in the malignant cells
11. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: Role in NF-kappaB activation
12. Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression
13. Hodgkin's disease derived cell lines: A review
14. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2
15. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production
16. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors
17. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1)
18. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence
19. Expression of interleukin 10 in B lymphocytes of different origin
20. Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers
21. Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions
22. Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation
23. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines
24. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: Role of the p38 and p42/44 mitogen-activated protein kinases
25. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins
26. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule
27. A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor- kappaB, and stress-activated protein kinase
28. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease
29. Distribution and phenotype of Epstein-Barr virus-harboring cells in Hodgkin's disease
30. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain
31. Three NF-kappa B sites in the I kappa B-alpha promoter are required for induction of gene expression by TNF alpha
32. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB
33. Tumor necrosis factor receptor associated factor 2 is a mediator of NF- kappaB activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein
34. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation
35. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues
36. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade
37. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor
38. The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome
39. Promotion of IL8, IL10, TNFalpha and TNFbeta production by EBV infection
40. The AT-rich region between -56 to -66 is important for the promoter activity of interleukin-10 in Epstein-Barr Virus positive Burkitt's lymphoma cells
41. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines
42. Expression of Epstein-Barr virus nuclear antigen 1 is associated with enhanced expression of CD26 in the Hodgkin cell line L428
43. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice
44. The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease
45. NF-kB only partially mediates Epstein-Barr virus latent membrane protein 1 activation of B cells
46. Multivalent DNA binding properties of the HMG-I proteins
47. Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma
48. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation
49. Stimulation of NF-kB-mediated transcription by mutant derivatives of the latent membrane protein of EBV
50. Interleukin-10
51. Interleukin-10 gene expression in adult T-cell leukemia
52. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
53. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines
54. Immunohistochemical detection of the Epstein-Barr virus-encoded latent membrane protein 2A in Hodgkin's disease and infectious mononucleosis
55. Normal and malignant B-cell development with special reference to Hodgkin's disease
56. Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation
57. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
58. Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival
59. Prognostic value of serum IL-10 and soluble IL-2 receptor levels in aggressive non-Hodgkin's lymphoma
60. Interleukin-10 as a regulatory cytokine induced by cellular stress: Molecular aspects
61. Interleukin 10 inhibits cytokine production of human AML cells
62. Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival